Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

AstraZeneca · Phase 2 · Completed · Enrollment 400

NCT00112021

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Pramlintide Acetaten/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • Pramlintide Acetate: endpoint not reported
  • Placebo: endpoint not reported